HSG Holding Ltd
An institutional investment manager in NA. Its Form 13F for the quarter ended Jun 30, 2026, filed Aug 13, 2026. SEC CIK 1470766.
- Reported value$1.24bn
- Positions20
Holdings: 20 positions
The filing on sec.govAs filed, largest first. Reported value is what the manager stated for each position at the quarter end, in US dollars; it is filing data, not a price. Weight is the position's share of the total reported value. Changes compare with the 13F for the quarter ended 2026-03-31. The filing's table has 27 lines; lines for the same security and option type are added together here.
| Issuer | Class | CUSIP | Reported value$m | Weight | Shares | Put or call | Change on the quarter before |
|---|---|---|---|---|---|---|---|
| PDD Holdings IncPDD | SPONSORED ADS | 722304102 | 866 | 72.3% | 11,348,426 | Unchanged | |
| Futu Holdings LtdFUTU | SPON ADS CL A | 36118L106 | 69.4 | 5.8% | 740,352 | Unchanged | |
| Pony Ai IncPONY | SPONSORED ADS | 732908108 | 52.4 | 4.4% | 7,538,358 | Unchanged | |
| Circle Internet Group IncCRCL | COM CL A | 172573107 | 41.9 | 3.5% | 669,200 | Unchanged | |
| KE Holdings IncBEKE | SPONSORED ADS | 482497104 | 28.2 | 2.4% | 1,939,017 | Unchanged | |
| Gyre Therapeutics IncGYRE | COM | 403783103 | 24.7 | 2.1% | 3,750,299 | New+3,750,299 | |
| Kanzhun LimitedBZ | SPONSORED ADS | 48553T106 | 24.5 | 2.0% | 1,900,000 | Unchanged | |
| Arrivent Biopharma IncAVBP | COM | 04272N102 | 23.0 | 1.9% | 663,308 | Unchanged | |
| Dingdong Cayman LtdDDL | ADS | 25445D101 | 19.5 | 1.6% | 10,091,839 | Unchanged | |
| Structure Therapeutics IncGPCR | SPONSORED ADS | 86366E106 | 14.3 | 1.2% | 266,062 | Unchanged | |
| 51TALK Online Education GrouCOE | SPONSORED ADR | 16954L204 | 7.6 | 0.6% | 474,901 | Unchanged | |
| Lotus Technology IncLOT | SPONSORED ADR | 54572F101 | 5.7 | 0.5% | 4,834,099 | Unchanged | |
| Adagene IncADAG | ADS | 005329107 | 5.6 | 0.5% | 1,343,364 | Unchanged | |
| TH International Limited | SHS NEW | G8656L130 | 5.5 | 0.5% | 2,900,606 | Unchanged | |
| Bitdeer Technologies Group | CL A ORD SHS | G11448100 | 4.7 | 0.4% | 293,732 | Unchanged | |
| Lyell Immunopharma IncLYEL | COM NEW | 55083R203 | 2.1 | 0.2% | 152,299 | Unchanged | |
| Solai Limited | SPON ADR | 055474209 | 1.1 | <0.1% | 350,427 | Unchanged | |
| Barinthus Biotherapeutics PL | ADS | 91864C107 | 0.9 | <0.1% | 1,420,473 | Unchanged | |
| Burning Rock Biotech LtdBNR | SPONSORED ADS | 12233L206 | 0.2 | <0.1% | 21,212 | Unchanged | |
| Yimutian Inc | SPONSORED ADS | 985915206 | 0.1 | <0.1% | 229,470 | New+229,470 |
Sold out: 2 positions
Held at the end of the quarter before and not reported this quarter.
| Issuer | Class | CUSIP | Reported value$ | Weight | Shares | Put or call | Change on the quarter before |
|---|---|---|---|---|---|---|---|
| Webull Corp | ORD SHS | G9572D103 | 0.0 | 0.0% | 0 | Sold out−7,053,639 | |
| Yimutian Inc | SPONSORED ADS | 985915107 | 0.0 | 0.0% | 0 | Sold out−3,442,060 |
Source: SEC EDGAR, Form 13F-HR, accession 0001193125-26-348168 (on sec.gov). Last ingested by Listed: Oct 22, 2026, 05:26 ET. Listed shows no prices and gives no investment advice.